Cyclotron production of Ac-225 for targeted alpha therapy

Applied Radiation and Isotopes

Volumn 62, Issue 3, 2005, Pages 383-387

  Apostolidis, C ^a   Molinet, R ^a   McGinley, J ^a   Abbas, K ^b   Mollenbeck J ^c   Morgenstern, A ^a  

^a EUROPEAN COMMISSION   (Belgium)

^b JOINT RESEARCH CENTRE   (Italy)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Actinium 225; Cyclotron; Radioisotope production; Radium 226; Targeted alpha therapy

Indexed keywords

AC-225; PROTON ENERGIES;

PROTON IRRADIATION; TUMORS;

CYCLOTRONS;

ACTINIUM; RADIUM 226;

ARTICLE; CANCER RADIOTHERAPY; CHEMICAL REACTION; CYCLOTRON; ENERGY; FEASIBILITY STUDY; PRIORITY JOURNAL; PROTON RADIATION; RADIOASSAY; SEPARATION TECHNIQUE;

ACTINIUM; ALPHA PARTICLES; CYCLOTRONS; NUCLEAR MEDICINE; PROTONS; RADIOTHERAPY; RADIUM;

EID: 10644227867     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2004.06.013     Document Type: Article

References (15)

1. B. Allen, Y. Li, S. Rizvi, and P.J. Russell Targeted alpha therapy of prostate cancer Methods Mol. Med. 81 2003 333 357
2. Ch. Apostolidis, R. Carlos-Marquez, W. Janssens, R. Molinet, T. Nikula, and A. Ouadi Cancer treatment using Bi-213 and Ac-225 in radioimmunotherapy Nucl. News 44 13 2001 29 33
3. Boll, R.A., Malkemus, D.W., Mirzadeh, S., 2003. Production of Ac-225 for alpha-particle-mediated radioimmunotherapy. Proceedings of the 225th ACS National Meeting, New Orleans, USA, March 23-27.
4. E. Dadachova, T. Burns, R.A. Bryan, C. Apostolidis, M.W. Brechbiel, J.D. Nosanchuk, A. Casadevall, and L. Pirofski Feasibility of radioimmunotherapy of experimental pneumococcal infection Antimicrob Agents Chemother 48 5 2004 1624 1629
5. 225Ac. Proceedings of the 225th ACS National Meeting, New Orleans, USA, March 23-27.
6. GUM (Guide for the Expression of Uncertainty in Measurements) Workbench, Version 2.3, 2001. Metrodata GmbH, Grenzach-Wyhlen, Germany.
7. R. Huber, Ch. Seidl, E. Schmid, S. Seidenschwang, K.-F. Becker, Ch. Schuhmacher, C. Apostolidis, T. Nikula, E. Kremmer, M. Schwaiger, and R. Senekowitsch-Schmidtke Locoregional α-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibody Clin. Cancer Res. 9 2003 3922 3928
8. Institute for Transuranium Elements (ITU), 1995. Annual Report EUR 16368, pp. 55-59.
9. J.G. Jurcic, S.M. Larson, G. Sgouros, M. McDevitt, R.D. Finn, C.R. Divgi, A.M. Ballangrud, K.A. Hamacher, D. Ma, J.L. Humm, M.W. Brechbiel, R. Molinet, and D.A. Scheinberg Targeted α particle immunotherapy for myeloid leukemia Blood 100 4 2002 1233 1239
10. S.J. Kennel, T. Lankford, S. Davern, L. Foote, K. Taniguchi, I. Ohizumi, Y. Tsutsumi, S. Nakagawa, T. Mayumi, and S. Mirzadeh Therapy of rat tracheal carcinoma IC-12 in SCID mice vascular targeting with [213Bi]-MAb TES-23 Eur. J. Cancer 38 9 2002 1278 1287
11. Liu, S.F., Allen, B.J., 2003. Transmutation of radium waste to Ac-225 for cancer therapy: theoretical calculation of yield. Proceedings of the World Congress on Medical Physics and Biomedical Engineering, Sydney, Australia.
12. J. Magill Nuclides.Net An Integrated Environment for Computations on Radionuclides and their Radiation 2003 Springer Germany
13. M. McDevitt, G. Sgouros, R.D. Finn, J.L. Humm, J.G. Jurcic, S.M. Larson, and D.A. Scheinberg Radioimmunotherapy with alpha-emitting nuclides Eur. J. Nucl. Med. 25 1998 1341 1351
14. 225Ac. Proceedings of the Third α-immuno-therapy Symposium, Heidelberg, Germany, June 3-4.
15. 213Bi-rituximab versus external gamma radiation for the treatment of B-CLL patients relative biological efficacy with respect to apoptosis induction and chromosomal damage Eur. J. Nucl. Med. Mol. Imaging 30 10 2003 1357 1364